BLAKE DRAIN UNKNOWN PRODUCT
Report
- Report Number
- 2210968-2018-71540
- Event Type
- Injury
- Date Received
- March 20, 2018
- Report Date
- February 20, 2018
- Manufacturer
- ETHICON INC.
- Product Code
- GBX
- PMA / PMN Number
- CL I EXEMPT
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MD, US
- Reporter Occupation
- HEALTH PROFESSIONAL
Narratives
PRODUCT COMPLAINT # (B)(4). DATE SENT TO THE FDA: 9/9/2020.
(B)(4). ATTEMPTS ARE BEING MADE TO OBTAIN THE FOLLOWING INFORMATION. TO DATE NO RESPONSE HAS BEEN PROVIDED. IF FURTHER DETAILS ARE RECEIVED AT A LATER DATE A SUPPLEMENTAL MEDWATCH WILL BE SENT. CITATION: J GASTROINTEST SURG (2015) 19:2054¿2061; DOI: 10.1007/S11605-015-2894-0. (B)(4)
JOURNAL ARTICLE TITLE: NEGATIVE-PRESSURE WOUND THERAPY IN THE MANAGEMENT OF HIGH-GRADE VENTRAL HERNIA REPAIRS THE STUDY AIMED TO IDENTIFY THE SURGICAL SITE OCCURRENCES (SSO) AND SURGICAL SITE INFECTION (SSI) RATES IN A LARGE GROUP OF GRADE 3 VENTRAL HERNIA PATIENTS USING THE USE OF A MODIFIED NEGATIVE-PRESSURE WOUND THERAPY (NPWT) SYSTEM (HYBRID-VAC OR HVAC). A FOUR YEAR REVIEW FROM JAN2011 TO DEC2014 WAS CONDUCTED AND 117 PATIENTS (N=50 MALE, N=67 FEMALE; MEAN AGE SD 56.7±11.9 YEARS) WITH GRADE 3 HERNIA UNDERWENT OPEN VENTRAL HERNIA REPAIR AND CONCOMITANT HVAC THERAPY WERE INCLUDED. IN THE PROCEDURE, #1 PROLENE INTERRUPTED SUTURES WERE USED WHEN MIDLINE FASCIA COULD NOT BE RE-APPROXIMATED. A PROLENE MESH ONLAY WAS USED TO COVER ABDOMINAL WALL. 0-PROLENE SUTURES WERE USED AS ANCHOR SUTURES AND TO SECURE MESH TO THE ABDOMINAL WALL. THREE TO FOUR #19 FLUTED DRAINS WERE PLACED AND LEFT IN THE SUBCUTANEOUS SPACE. AT 90-DAY FOLLOW-UP, SSO INCLUDED SUPERFICIAL SSI (N=6), SEROMA (N=15) AND ENTEROCUTANEOUS FISTULA (N=2). THE PATIENT ALSO HAD WOUND-RELATED REOPERATION (N=6). ADDITIONAL INFORMATION HAS BEEN REQUESTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 198570 | BLAKE DRAIN UNKNOWN PRODUCT | CATHETER, IRRIGATION | GBX | ETHICON INC. |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Required Intervention |